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Simple Summary: Metabolic bone disease can have disastrous consequences on canine health. Un-
like in human medicine where awareness of osteoporosis and bone mineral density (BMD) disorders
have led to the holistic application of osteodensitometry, application of osteodensitometry in dogs is
limited. We aimed to assess the utility of quantitative computed tomography (qCT) bone mineral den-
sity (BMD) measurement of the canine calvarium using semiautomated osteodensitometry software
and define host factors associated with canine BMD in a skeletally healthy population. Calvarium
qCT can be used to rapidly obtain BMD measurement of dogs. Canine BMD was negatively associ-
ated with weight, whereas there was no relationship between BMD and age or sex. Many chronic
canine diseases can significantly affect bone health via a variety of pathophysiological mechanisms.
This efficient qCT method could facilitate rapid BMD screening in dogs undergoing CT evaluation
and ultimately encourage further BMD investigation.
Abstract: Despite bone mineral density (BMD) being regularly measured in human patients, BMD
studies in clinical cohorts of dogs is lacking. In order to facilitate BMD assessment and in turn better
identify dogs suffering from metabolic bone disease, rapid, easy and precise computed tomography
(qCT) techniques are required. In this study we aimed to assess the utility of quantitative computed
tomography (qCT) bone mineral density (BMD) measurement of the canine calvarium using a semi-
automated osteodensitometry software and define host factors associated with canine bone mineral
density in a skeletally healthy population. Calvarial qCT at the level of the temporomandibular
joints was performed on 323 dogs using a dedicated osteodensitometry calibration phantom during a
clinically indicated head computed tomography (CT). Calvarial BMD was analyzed using a dedicated
semiautomatic osteodensitometry software for contouring of the calvarial lamellar bone margins
and BMD calculation. The mean duration of the calvarial qCT scanning was 64.6 s, and the mean
duration of BMD analysis was 34 s, with a mean of two manual adjustments required for the bone
margin tracing. The median BMD of all dogs in our study was 659 mg Calcium hydroxyapatite/mL.
There was a negative linear correlation between BMD and body weight, but no correlation with age,
sex or neutered status. Canine BMD assessment using qCT of the calvarium is a practical and fast
technique that can be added to a clinical CT examination with minimal extra time requirements.
Canine BMD host-dependent factors exhibit different relationships from that of humans; however,
further investigation is warranted.
Keywords: bone marrow density; osteodensitometry; bone marrow; computed tomography
1. Introduction
Metabolic bone disease (MBD) is an important cause of morbidity in dogs. Numerous
metabolic diseases can cause skeletal pathology including primary hyperparathyroidism
and secondary hyperparathyroidism resulting from nutritional deficiencies or renal dis-
Animals 2021, 11, 1413. https://doi.org/10.3390/ani11051413 https://www.mdpi.com/journal/animals
Animals 2021, 11, 1413 2 of 12
ease [1–3]. In extreme cases, MBD can cause bony hyperaesthesia, bone loss (osteopenia)
and pathologic fractures [4,5].
Despite the devastating impact MBD can have on the welfare of dogs, it remains
challenging to accurately and rapidly assess skeletal health in most veterinary care settings.
This contrasts with the human sector where the assessment of skeletal health by the
evaluation of bone density using dual energy x-ray absorptiometry (DEXA) scans or
computed tomography (CT)-based technologies are well established techniques [6]. These
techniques are regularly incorporated into health metrics that can help guide medical
and nutritional interventions for a variety of skeletal and extra-skeletal conditions [7–9].
Both modalities are heavily employed in the screening of osteoporosis [10]. Use of these
techniques provides clinicians with an opportunity to detect bone mineral density changes
early in a disease process and initiate therapy to reduce future morbidity [11].
Historically, radiographs were the modality of choice to evaluate bone density and
diagnose osteopenia in dogs. However, the sensitivity of radiography to detect bone
density abnormalities is poor, with at least 40% of bone loss occurring prior to radiographic
detection [12]. Radiographic interpretation is also subjective and influenced by technical
and operator factors [13]. Only a small number of studies have assessed bone density using
DEXA and qCT protocols in animals [14–16]. To date, studies investigating bone density in
dogs have typically utilized human methodologies, focused on small research populations
using techniques originally designed for people in which the femur and lumbar vertebrae
are used to assess bone density [14,17]. However, bone mineral density (BMD) changes
precipitated by extra-skeletal disease are not restricted to lumbar vertebrae [1,2,18]. In
fact, bones of the skull are particularly susceptible to effects of nutritional deficiencies in
both humans and dogs and contribute toward pathological fractures and cause “rubber
jaw,” which results from the replacement of mandibular bone with fibrocartilaginous
tissue [19–23]. A recent report of nutritional secondary hyperparathyroidism in a dog
highlighted that skull bone density can be lower in dogs fed a nutritionally incomplete
diet [2]. The possibility of employing CT to assess BMD of the skull bones in dogs is
an appealing concept. It would circumvent the need for laborious positioning, reduce
anesthetic time or avoid general anesthesia and has the potential to become the standard of
practice for dogs undergoing CT for clinical diagnostics.
We hypothesized that osteodensitometric qCT of the canine head will be fast to
perform in sedated or anaesthetized dogs; that BMD results can be fast and easily calculated;
and that lower weight, higher age, female dogs and neutered dogs will be negatively
associated with BMD.
Here we report a novel approach to qCT BMD measurement in the calvarium of a
cohort of dogs without skeletal disease. We have then used this technique to define the
host factors associated with canine BMD in dogs with no clinical signs of skeletal disorders.
2. Materials and Methods
2.1. Animal Selection
This study was a prospective clinical cohort study performed on dogs undergoing
CT examination for a primary clinical reason for a non-skeletal disease at the Royal (Dick)
School of Veterinary Studies’ Hospital for Small Animals. Medical and imaging records
from dogs that underwent a general anesthesia or sedated computed tomography (CT)
examination that included a qCT examination of the head between May 2015 and July
2019 were prospectively gathered. The study was ethically approved by the University
of Edinburgh’s Veterinary Ethical Research Committee (institutional reference number
VERC 99 14).
Computed tomography studies were all initially clinically evaluated by a senior
board-certified veterinary radiologist (T.S. and T.L.). Studies with non-diagnostic quality
in which BMD could not be calculated were excluded first and causes of exclusion were
recorded. Dogs with evidence of intranasal disease extending to the skull and intracranial
disease involving the hypothalamus pituitary axis structures were also excluded from
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BMD assessment. Additional exclusion criteria for the study included any medical history
or suspected underlying pathology that could predispose the dog to generalized bone
disease, metabolic disorders or malignancy, trauma or implants at the measurement sites,
or any medical treatments with progestogens, steroids or bisphosphonates that are known
to affect bone metabolism and density. Dogs below the age of 12 months were excluded.
2.2. Quantitative CT Examination
Computed tomography images of the head were acquired by use of a 4-slice helical
CT scanner (Volume Zoom®, Siemens, Erlangen, Germany) before October 2016 and a
64-slice helical CT scanner (Somatom® Definition AS Siemens, Erlangen, Germany) after
that time with a dedicated osteodensitometry calibration phantom (model number 8783219,
Siemens, Munich, Germany). A helical CT scan without contrast medium application was
performed as part of all dogs’ diagnostic investigation under sedation or general anesthesia.
Dogs were kept in sternal recumbency throughout the scan. The dog was not moved after
scanning was initiated. The examinations were performed by various imaging diagnostic
residents assisted by an experienced radiographer and supervised by two authors of the
study (T.S or T.L.). The osteodensitometry phantom was placed on the table under the
head of all dogs (Figure 1). The osteodensitometry phantom contains one chamber with
demineralized water (reference value 0 Hounsfield units (HU) and one chamber with
calcium hydroxyapatite (CaHAP) with a concentration of 200 mg/mL.
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or in a dedicated slot within the cushioning material of the CT patient table (see inset upper right
corner).
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The CT table height was adjusted to the gantry center (125 mm table height) according
to the manufacturer’s guidelines to ensure repeatability for all forthcoming BMD mea-
surements. The table location of each dog’s temporomandibular joint was determined
by one author (T.S.) and one additional single slice CT scan with 10 mm slice thickness
was obtained at the level of the temporomandibular joint with the following settings: 80
kV, 1 s tube rotation time, 10 mm slice collimation, 512 × 512 matrix, 250 mm image
reconstruction diameter. The electric current was automatically and individually selected
by an automatic exposure control system (Care Dose 4D, Siemens Medical Solutions, In-
ternational, Erlangen, Germany) depending on the body size and shape on the topogram
scan. This resulted in different mAs settings between the dogs (range 20 to 150 mAs). The
image was then reconstructed with 10 mm slice width using a dedicated reconstruction
kernel (S80s, Siemens, Erlangen, Germany). The osteodensitometry function was identical
between both CT units, and hence the technical factors for the CT scans were the same. All
images acquired were stored on a local archiving and communication software. All studies
were reviewed on an Apple Mac Pro® (Apple, Cupertino, CA, USA) with a calibrated flat
screen monitor, using a dedicated, open-source DICOM viewer software (Horos, Purview,
Annapolis, MD, USA, version 3.3.6).
BMD was analyzed using a dedicated semiautomatic contouring software (Osteo,
Siemens, Erlangen, Germany) that is designed to identify the cortical and trabecular bone
of a lumbar vertebra (Figure 2A,B) and calculates mean BMD in mg/mL according to the
following formula:
Mean BMD = 200 mg/mL
HUt
HUb − HUw (1)
where HUt is the measured density of the bone in HU, HUb is the measured density of the
CaHAP solution of the phantom in HU, HUw is the measured density of demineralized
water of the phantom in HU and 200 mg/mL is the concentration of the CaHAP solution
in the phantom. The software-generated cortical bone traces were applied to lamellar bone
of the calvarium, manually adjusted and measured the squamous part of the temporal
and parietal bone at the level of the temporomandibular joint. The software-generated
trabecular bone traces were attempted to be adjusted to the diploë (trabeculated skull
bone) of the calvarium (Figure 2C–F). The BMD analysis was performed by qualified
radiographers and radiologists who were specifically trained on the use of this software.
Calculated mean BMD values were recorded for each dog.
In order to assess the ease and speed of the CT osteodensitometry scanning procedure
and the bone mineral density calculation, 15 CT studies were randomly selected. In these
studies, the time of acquisition of the last image of the last CT series prior to the qCT
study and the acquisition time of the last qCT image were recorded and the time difference
was calculated. The duration of the measurement process and the number of corrections
applied using the osteodensitometry contouring software were also recorded.
2.3. Statistical Analysis
Statistical analyses were performed using the R Statistical System [24]. Analysis of the
association between mean and sd bone density-dependent variables and age, body weight,
sex and neuter status predictors was performed using multivariable linear regression and
including CT machine as a covariate. A subset of 40 dogs of similar weight and breed
were selected to compare the effect of CT machine on osteodensitometry measurement. Re-
estimation of the regression model including CT unit was performed and it was concluded
that the CT unit was not a significant predictor and that estimates of significant effects did
not change. Furthermore, direct comparison between each CT unit’s osteodensitometry
measurement was performed using a subset of 40 similar breed dogs of similar weight and
demonstrated overlap of confidence intervals.
For analysis of sex-related differences, the dogs were coded into four groups: intact
males, intact females, neutered males and neutered females. Initially models were fitted
using age, weight and sex variables. Then variables with effects that were not significantly
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different from zero were removed. Then, the effect on significant variables of adding
back in removed variables was assessed. T-tests were used to determine significance of
individual predictors, with p-values < 0.05 considered significant. As continuous predictors
(age and weight) may have a non-linear relationship with mean BMD, linear models were
then compared using models in which significant continuous predictors were divided
into categories by quartile. Final model residuals were assessed for normality using QQ
plots and models with residuals deviating from normality were re-estimated without the
relevant observations to assess the impact. For osteodensitometry CT scanning and BMD
measurement duration, the mean time span with 95% confidence interval was calculated.
For BMD measurements, the mean number of corrections with 95% confidence interval
was calculated.
3. Results
3.1. Population Data
The CT osteodensitometry examinations of 448 dogs were initially gathered. A total
of 48 dogs (10.7%) were excluded due to insufficient image quality of the qCT image to
perform the BMD calculation. This was due to absence of the osteodensitometry phantom in
the qCT image (16 dogs) or inappropriate positioning (32 dogs). Inappropriate positioning
included slice location out with the level of the temporomandibular joints, excessive
obliquity of the head or the phantom, and an excessive distance between the head and
the phantom. A further 77 dogs were excluded due to age at time of qCT (<12 months);
pathology of the head at the level of the BMD qCT slice; the presence of history, clinical exam
and biochemical findings consistent with a pathology reported to affect BMD; detection
of metastatic neoplastic disease and the recent use of glucocorticoid or bisphosphonate
treatment. Two were excluded from the regression modelling as they had missing weight
data. Hence a total of 323 dogs were included in the study. One hundred and ninety-two
dogs were male, of which 120/192 (62.5%) were neutered. One hundred and thirty-one
dogs were female, of which 98/131 (74.8%) were neutered. There was a large variation
in the breeds of dog undergoing CT. The 5 most common breeds in this referral cohort
were Labrador Retriever (26), Bulldog (22), Cocker Spaniel (16), Springer Spaniel (15) and
cross breed (10). The median age of all dogs was 7 years (range 1–13.9 years). The median
weight of the dogs included was 20 kg (range 1.7–59.8 kg).
3.2. Osteodensitometry Procedure
It was possible to obtain a diagnostic-quality lamellar calvarial bone osteodensito-
metry in all 323 dogs included in the study. Diploë was only present in a small number of
dogs, and could not be measured accurately due to averaging with brain tissue and this
was therefore not recorded (Figure 2E,F). The CT osteodensitometry scanning procedure
had a mean duration of 64.6 s (95% confidence interval of 44–85 s). The CT osteodensito-
metry BMD measurement procedure was obtained with a mean number of 2 corrections
(95% confidence interval of 1.4 to 2.0 corrections) and had a mean duration of 34 s (95%
confidence interval of 28.9–39.1 s).
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3.3. Bone Mineral Density Analysis
The median BMD of all dogs in our study was 659 mg CaHAP/mL. The final linear
regression model of mean BMD showed a negative relationship with weight; mean BMD de-
creased by 1.64 units (95% CI 0.67–2.61, p < 0.001) per kg increase in weight (Figure 3). Age
and sex were not significant predictors and the relationship appeared to be approximately
linear over the available data (Figures 4 and 5).
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4. Discussion
In thi tudy, we report a novel qCT approach to assess BMD using lamellar bone of
the canine calvarium.
Our hypotheses that osteodensitometric qCT of the canine head would be fast to
perform in sedated or anaesthetized dogs; that BMD results are easy and quick to calculate;
and that lower weight would be n gatively associated with BMD were confirmed. O r
hypotheses th t increased ge, female an neutered dogs would be negatively associated
with BMD were not confirmed.
Although unreported in veterinary literature, the validity of measuring the skull
bones for assessment of bone density has been well explored in the human field [25–28].
Bone mineral density of the skull bones is well correlated to the rest of the skeleton [28].
The measurement of BMD from the v rtebral column, hips and wrists in pe ple carry
a number of technical uncertainties that make skull bone density measurements more
appealing [29–32]. The qCT imaging technique featured in this paper was easy to perform
and results obtained were in keeping with previous cadaveric studies [33].
Canine body weight was negatively correlated with BMD in this study. The rela-
tionship between weight a d BMD is heavily underpinned y the complex interaction
between adipose and osteoblast cells [34]. A recent study in humans has documented
that abdominal fat and bone marrow adipose tissue are associated with increased cortical
porosity and a reduced rate of bone formation [35]. As body condition score of dogs was
not performed conclusions are based on absolute patient weight and associations between
BMD and lean body weight cannot be assessed.
In contrast to findings f this study, BMD of the head decreases with age in hu-
mans [28]. Bone is a dynamic structure that is continually remodeling. With increasing
age there is a distinct shift toward greater bone resorption and less bone synthesis. Many
extrinsic factors contribute to BMD in aging humans and animals including diet, exercise
and drugs [30,31]. In our study, dogs receiving medication known to affect bone health
were exclu ed, but ur study design did not allow u to assess diet or accurately deduce
exercise level.
In humans, the difference in BMD between men and women is stark [36]. Estrogen
plays a vital role in female bone health. Decreased estrogen hastens bone loss and sig-
nificantly decreases BMD in women [37]. Results of this study failed to show a similar
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relationship when comparing sex. Furthermore, neuter status did not contribute toward
a difference in BMD between male and female dogs. This was an unexpected finding
as estrogen and the effects of gonadectomy on bone density have been previously docu-
mented in dogs [38]. The exact date of gonadectomy was unknown in the dogs within
this population. The effect of gonadal steroid deficiency on bone mineral density is not
instantaneous. This could account for a proportion of neutered dogs retaining normal BMD
and lack of significant difference.
The technique featured in this study measured lamellar BMD using qCT. In human
patients both DEXA and qCT focus on assessment of trabecular bone. The trabecular bone
is the metabolically most active compartment of bone and sensitive to systemic disease [39].
That being said, in humans, trabecular bone lacks uniformity [39] and in turn incurs
BMD measurement uncertainty. Given that the calvarium consists of mainly homogenous
lamellar bone similar to cortical bone [25], that cortical bone is affected by age related
changes [39] and that a strong correlation exists between skull and whole body BMD in
humans [28], the use of lamellar bone in this study was justified. However, future studies
are needed to compare BMD obtained from canine lamellar and trabecular bone.
The median BMD in our study population was similar to cortical BMD reported in
previous studies [33,40]. The calvarium is formed from intramembranous ossification [41].
Intramembranous ossification creates a tight, interwoven matrix of osteoblasts and colloid
which is denser than bones arising from endochondral ossification which are percolated
with chondroblasts and fibrous tissue. In humans the porosity of cortical bone is predictive
of fractures [42]. Cortical bone is only affected by most severe metabolic disease [42] and
therefore makes it less likely that subclinical disorders of dogs enrolled into the study
affected BMD results.
In recent years, research in human medicine has moved away from DEXA scans and
become focused on measuring BMD using qCT [43,44]. This has been promoted in order
to reduce additional radiation exposure. Thus, CT scans have become an opportunity
to obtain a global assessment of BMD. It is accepted that CT supersedes DEXA scans in
veterinary patients when extreme variety of patient sizes and soft tissue dimensions render
DEXA values inaccurate [45]. Veterinary publications that address qCT BMD are limited
by small case numbers, use of cadavers, or use of a research population [14,40,46–49]. Our
study contains a large population of clinical dogs and highlights that BMD can be assessed
almost seamlessly in dogs undergoing CT for other clinical indications.
Computed tomography has become a gold standard for many conditions and therefore
is now frequently performed in dogs, in particular for the head [50]. CT units used in
veterinary practice are designed for human patients and have integrated osteodensitometry
applications. Our study demonstrates that these integrated applications can be used in dogs
undergoing head CT under sedation or general anesthesia quickly and are easily adaptable
for the canine calvarium. This opens many new opportunities for screening of bone health
status and bone metabolism in dogs, associated prognostic criteria and monitoring of
treatment regimes. The fact that 10.7% of studies had an insufficient image quality to
measure BMD predominantly due to positioning errors emphasizes the importance of
operator training and quality control regimes.
There were a number of limitations in this study. The gold standard for BMD mea-
surement is bone ash analysis [6,51] which could not be integrated in this clinical study
given client-owned dogs rarely undergo postmortem examination. Despite a large number
of dogs involved in this study, the total number of dogs of each breed was generally small
and therefore the authors were unable to conclude any reliable breed-specific BMD results.
Without a breed-specific BMD assessment, the authors advise cautious interpretation of
osteodensitometry values based on the empirical weight groups chosen for this study.
Previous studies in humans and dogs have predominantly used trabecular bone of lumbar
vertebrae for BMD analysis. It was not feasible within the context of this study to add lum-
bar measurement to the head qCT performed, and there was no consistently measurably
trabeculated bone in the skull. Cortical and presumably lamellar bone is less metabolically
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active than trabecular bone [39]. This may account for the negligible effect of age and sex
on BMD in this study. Furthermore, there was a large range of dog breeds involved in
this study, all with varied diets and exercise regimes. These factors could significantly
alter cortical bone density and limits our ability to draw on cortical and trabecular bone
correlation in humans, where these factors were better controlled. Inter-operator variability
of BMD calculation was not measured in this study. Although dogs participating in this
study showed no obvious clinical signs of bone disease, dogs were not systematically
screened for diseases affecting bone metabolism. It is therefore possible that dogs suffering
from diseases impacting on BMD were included in the study and the authors recommend
cautious interpretation of these preliminary results.
5. Conclusions
In conclusion, this study revealed that skull-based qCT in sedated or anaesthetized
dogs is a practical diagnostic test that can be added with minimal additional time to head
CT studies. Using the semiautomatic tracing software integrated in CT units for the canine
lamellar calvaria bone, BMD can be measured easily and quickly. The calvarium of bone
healthy dogs has a median BMD of 659 mg CaHAP/mL, and BMD is negatively correlated
with weight, but there is no correlation with age, sex or neutered status.
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